Physician profile
Michael Stencel
NPI 1881041374
$4,526.67
in general payments reported to CMS, 2019-2025
19 companies · $559 in 2025
The $559 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.53 · 2020: $102 · 2021: $49.56 · 2022: $80.84 · 2023: $134 · 2024: $3,514 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625 · Education: $1,500 · Travel and Lodging: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.40 |
| Education | $1,500.00 |
| Travel and Lodging | $1,082.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,932.90 | 2024 | |
| Janssen Scientific Affairs, LLC | $377.31 | 2024-2025 | Erleada, Akeega, Balversa |
| Astellas Pharma US INC | $209.69 | 2023-2025 | Xtandi |
| Pfizer INC. | $189.52 | 2019-2025 | |
| Boston Scientific Corporation | $151.31 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $89.99 | 2023-2025 | Prolaris |
| Bioprotect Medical, INC. | $88.29 | 2025 | Bioprotect Balloon Implant System |
| Dendreon Pharmaceuticals LLC | $81.17 | 2024-2025 | Provenge |
| Coloplast Corp | $80.84 | 2022 | |
| Olympus America INC. | $74.90 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $72.70 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $32.85 | 2024-2025 | Orgovyx |
| Novartis Pharmaceuticals Corporation | $26.66 | 2025 | |
| Endo Pharmaceuticals INC. | $24.52 | 2023 | Xiaflex |
| Abbvie INC. | $21.92 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $20.46 | 2024 | |
| Procept Biorobotics Corporation | $19.83 | 2025 | |
| Janssen Biotech, INC. | $16.50 | 2023 | |
| Photocure INC | $15.31 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stencel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.